Hilde Gillijns
Overview
Explore the profile of Hilde Gillijns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu M, Pokreisz P, Claus P, Casazza A, Gillijns H, Caluwe E, et al.
Basic Res Cardiol
. 2024 Aug;
119(5):795-806.
PMID: 39090343
Placental growth factor (PlGF)-2 induces angio- and arteriogenesis in rodents but its therapeutic potential in a clinically representative post-infarction left ventricular (LV) dysfunction model remains unclear. We, therefore, investigated the...
2.
Algoet M, Pusovnik M, Gillijns H, Mestdagh S, Billiau J, Artoos I, et al.
J Vis Exp
. 2024 Apr;
(205).
PMID: 38587368
Acute myocardial infarction (AMI) is a prevalent and high-mortality cardiovascular condition. Despite advancements in revascularization strategies for AMI, it frequently leads to myocardial ischemia-reperfusion injury (IRI), amplifying cardiac damage. Murine...
3.
Wu M, Pelacho B, Claus P, De Buck S, Veltman D, Gillijns H, et al.
Eur J Pharm Biopharm
. 2023 Jan;
184:83-91.
PMID: 36693545
Nanomedicine offers great potential for the treatment of cardiovascular disease and particulate systems have the capacity to markedly improve bioavailability of therapeutics. The delivery of pro-angiogenic hepatocyte growth factor (HGF)...
4.
Van den Eynde J, Jacquemyn X, Cloet N, Noe D, Gillijns H, Lox M, et al.
J Am Heart Assoc
. 2022 Oct;
11(20):e027593.
PMID: 36205249
Background Arteriovenous fistulae (AVFs) are the gold standard for vascular access in those requiring hemodialysis but may put an extra hemodynamic stress on the cardiovascular system. The complex interactions between...
5.
Veltman D, Wu M, Pokreisz P, Claus P, Gillijns H, Caluwe E, et al.
JACC Basic Transl Sci
. 2021 Sep;
6(8):631-646.
PMID: 34466750
The bacterial C-type lectin domain family 4 member E (CLEC4E) has an important role in sterile inflammation, but its role in myocardial repair is unknown. Using complementary approaches in porcine,...
6.
Trenson S, Hermans H, Craps S, Pokreisz P, de Zeeuw P, Van Wauwe J, et al.
Circ Heart Fail
. 2021 Jan;
14(1):e006979.
PMID: 33464950
Background: Chronic pressure overload predisposes to heart failure, but the pathogenic role of microvascular endothelial cells (MiVEC) remains unknown. We characterized transcriptional, metabolic, and functional adaptation of cardiac MiVEC to...
7.
Vanhaverbeke M, Vausort M, Veltman D, Zhang L, Wu M, Laenen G, et al.
Circ Genom Precis Med
. 2019 Nov;
12(12):e002656.
PMID: 31756302
Background: The identification of patients with acute myocardial infarction (MI) at risk of subsequent left ventricular (LV) dysfunction remains challenging, but it is important to optimize therapies. The aim of...
8.
Vanhaverbeke M, Veltman D, Pattyn N, De Crem N, Gillijns H, Cornelissen V, et al.
Clin Cardiol
. 2018 Jun;
41(9):1201-1206.
PMID: 29952015
Background: Acute myocardial infarction (MI) invokes a large inflammatory response, which contributes to myocardial repair. Hypothesis: We investigated whether C-reactive protein (CRP) measured during MI vs at 1 month follow-up...
9.
Walravens A, Vanhaverbeke M, Ottaviani L, Gillijns H, Trenson S, Vanden Driessche N, et al.
Sci Rep
. 2018 Jun;
8(1):9266.
PMID: 29915261
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has intensified clinical trials to induce cardiac regeneration in the adult mammalian heart using different progenitor...
10.
Wu M, Pokreisz P, Swinnen M, Caluwe E, Gillijns H, Vanden Driessche N, et al.
J Cardiovasc Transl Res
. 2017 Apr;
10(4):348-358.
PMID: 28397162
Angiogenic growth factor therapy for ischemic cardiovascular disease carries a risk of stimulating atherosclerotic plaque growth. We evaluated risk benefit ratio of sustained administration of recombinant human placental growth factor...